Pfizer apologises for confusion following Lyrica NHS ruling

09-06-2015

Pfizer apologises for confusion following Lyrica NHS ruling

urbanbuzz / Shutterstock.com

Pfizer has apologised to UK-based healthcare providers for any confusion or increased workload following the English High Court’s decision on a patent infringement case centring on its epilepsy drug Lyrica (pregabalin).


Pfizer, Lyrica, NHS, second medical use patent, Actavis

LSIPR